Cite

HARVARD Citation

    Cunha, M. et al. (2021). Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. Journal for immunotherapy of cancer. 9 (7), p. . [Online]. 
  
Back to record